Natl Toxicol Program Tech Rep Ser. 2007 Nov(543):1-210.
alpha-Methylstyrene is used in the production of acrylonitrile-butadiene-styrene resins and copolymers, which improve the impact and heat-resistant properties of polymers, specialty grades of plastics, rubber, and protective coatings. alpha-Methylstyrene also moderates polymerization rates and improves product clarity in coatings and resins. Low molecular weight liquid polymers are used as plasticizers in paints, waxes, adhesives, and plastics. alpha-Methylstyrene was nominated by the U.S. Environmental Protection Agency for toxicologic evaluation and genotoxicity studies based on its high production volume and limited information available on its toxicity. Male and female F344/N rats and B6C3F1 mice were exposed to alpha-methylstyrene (99.5% pure) by inhalation for 3 months or 2 years. Inhalation studies were conducted because the primary route of human exposure is via inhalation. Genetic toxicology studies were conducted in Salmonella typhimurium, cultured Chinese hamster ovary cells, and mouse peripheral blood erythrocytes. 3-MONTH STUDY IN RATS: Groups of 10 male and 10 female rats were exposed by whole-body inhalation to alpha-methylstyrene at concentrations of 0, 75, 150, 300, 600, or 1,000 ppm for 6 hours per day, 5 days per week for 14 weeks. Additional clinical pathology groups of 10 male and 10 female rats were exposed to the same concentrations for 23 days. All rats survived to the end of the study, and mean body weights of all exposed groups were similar to those of the chamber controls. Kidney weights were significantly increased in 1,000 ppm males and 600 and 1,000 ppm females. Statistically significant increases in liver weights occurred in 150 ppm or greater males and 600 and 1,000 ppm females. The incidences of renal hyaline droplet accumulation were similar between exposed groups and chamber control groups, but the severity of hyaline droplet accumulation in 600 and 1,000 ppm males was greater than in chamber controls. Consistent with the hyaline droplet accumulation, an exposure-related increase in alpha2μ-globulin was detected in the kidneys of males exposed to alpha-methylstyrene. Morphologic changes were not detected in the liver. 3-MONTH STUDY IN MICE: Groups of 10 male and 10 female mice were exposed by whole-body inhalation to alpha-methylstyrene at concentrations of 0, 75, 150, 300, 600, or 1,000 ppm for 6 hours per day, 5 days per week for 14 weeks. Two female mice in the 1,000 ppm group died before exposure on day 3. Final mean body weights of 600 and 1,000 ppm males and 75, 300, and 1,000 ppm females were significantly less than those of the chamber controls; final mean body weight gains of mice exposed to 300 ppm or greater were also significantly less. Moderate to severe sedation (males only) and ataxia were observed in 1,000 ppm mice. The absolute liver weights of 600 and 1,000 ppm females and the relative liver weights of 300, 600, and 1,000 ppm males and females were significantly increased. The estrous cycle lengths of 600 and 1,000 ppm female mice were significantly longer than that of the chamber controls. Minimal to mild centrilobular hypertrophy was present in the livers of male and female mice exposed to 600 or 1,000 ppm alpha-methylstyrene. The incidences of exposure-related nasal lesions, including atrophy and hyperplasia of Bowman's glands and atrophy and metaplasia of the olfactory epithelium, were significantly increased in all exposed groups of males and females. The incidences of hyaline degeneration, characterized by the accumulation of eosinophilic globules in the cytoplasm of the respiratory epithelium, were significantly increased in females exposed to 150 ppm or greater. 2-YEAR STUDY IN RATS: Groups of 50 male and 50 female rats were exposed by whole body inhalation to alpha-methylstyrene at concentrations of 0, 100, 300, or 1,000 ppm for 6 hours per day, 5 days per week, except holidays, for 105 weeks. Survival rates of exposed male and female rats were similar to those of the chamber controls. The mean body weights of 1,000 ppm males and females were less than those of the chamber control groups during year 2 of the study. Two 1,000 ppm males and one 300 ppm male had renal tubule carcinomas, and one 300 ppm male had a renal tubule adenoma. Because of the neoplasms observed in 300 and 1,000 ppm males at the end of the 2-year study and the finding of alpha2μ-globulin accumulation in the kidneys at 3 months, which is often associated with kidney neoplasms, additional step sections of kidney were prepared; additional males with focal hyperplasia or adenoma were identified. The incidences of renal tubule adenoma and carcinoma (combined) in the 1,000 ppm males were significantly greater than those in the chamber controls when the single and step sections were combined. The incidence of mineralization of the renal papilla was significantly increased in 1,000 ppm males. The incidence of mononuclear cell leukemia in 1,000 ppm males was significantly increased compared to the chamber controls. In the nose, the incidences of basal cell hyperplasia were significantly increased in all exposed groups of males and females, and the incidences of degeneration of the olfactory epithelium were increased in 1,000 ppm males and females and 300 ppm females. 2-YEAR STUDY IN MICE: Groups of 50 male and 50 female mice were exposed by whole body inhalation to alpha-methylstyrene at concentrations of 0, 100, 300, or 600 ppm for 6 hours per day, 5 days per week, except holidays, for 105 weeks. Survival of all exposed male and female mice was similar to that of the chamber control groups. Mean body weights of 600 ppm males were less than those of the chamber control group throughout the study, and those of 600 ppm females were less after week 13. The mean body weights of 300 ppm males and females were less than those of the chamber controls during much of the study, but these groups recovered by the end of the study. The incidences of hepatocellular adenoma or carcinoma (combined) were significantly increased in the 100 and 600 ppm males and in all exposed groups of females. The incidences of hepatocellular adenoma were significantly increased in all exposed groups of females, and the incidences in all exposed groups of males and females exceeded the historical range for chamber controls. The incidences of hepatocellular carcinoma and eosinophilic foci of the liver were significantly increased in 600 ppm females. The incidences of olfactory epithelial metaplasia and hyperplasia of the glands overlying the olfactory epithelium were significantly increased in all exposed groups of males and females. In addition, atrophy of the olfactory epithelium was significantly increased in 300 and 600 ppm males. The incidence and severity of nephropathy were increased in 600 ppm females compared to chamber controls. Epithelial hyperplasia of the forestomach also was present in male mice.
alpha-Methylstyrene was not mutagenic in four strains of Salmonella typhimurium, with or without rat or hamster liver metabolic activation enzymes (S9). alpha-Methylstyrene did not induce chromosomal aberrations in cultured Chinese hamster ovary cells, with or without S9 activation, but did significantly increase the frequency of sister chromatid exchanges in cultures exposed in the presence of S9. In vivo, no significant increases in the frequencies of micronucleated erythrocytes were seen in blood samples of male mice obtained at the conclusion of the 3-month study. However, in female mice from the 3-month study, a significant increase in micronucleated erythrocytes was observed in the 1,000 ppm group.
Under the conditions of this 2-year inhalation study, there was some evidence of carcinogenic activity of alpha-methylstyrene in male F344/N rats based on increased incidences of renal tubule adenomas and carcinomas (combined). The increased incidence of mononuclear cell leukemia in 1,000 ppm male F344/N rats may have been related to alpha-methylstyrene exposure. There was no evidence of carcinogenic activity of alpha-methylstyrene in female F344/N rats exposed to 100, 300, or 1,000 ppm. There was equivocal evidence of carcinogenic activity of alpha-methylstyrene in male B6C3F1 mice based on marginally increased incidences of hepatocellular adenoma or carcinoma (combined). There was clear evidence of carcinogenic activity of alpha-methylstyrene in female B6C3F1 mice based on increased incidences of hepatocellular adenomas and carcinomas. Exposure of rats to alpha-methylstyrene resulted in kidney toxicity, which in males exhibited some features of alpha2μ-globulin nephropathy. Exposure to alpha-methylstyrene resulted in nonneoplastic lesions of the nose in male and female rats and mice and of the liver and kidney in female mice.
α-甲基苯乙烯用于生产丙烯腈-丁二烯-苯乙烯树脂和共聚物,这些产品可改善聚合物、特种塑料、橡胶及防护涂料的抗冲击和耐热性能。α-甲基苯乙烯还可调节聚合速率,并提高涂料和树脂的产品透明度。低分子量液体聚合物用作涂料、蜡、粘合剂及塑料中的增塑剂。由于α-甲基苯乙烯产量高且关于其毒性的信息有限,美国环境保护局将其列为毒理学评估和遗传毒性研究对象。对F344/N雄性和雌性大鼠以及B6C3F1雄性和雌性小鼠进行了为期3个月或2年的α-甲基苯乙烯(99.5%纯品)吸入暴露实验。进行吸入研究是因为人类主要的暴露途径是吸入。在鼠伤寒沙门氏菌、培养的中国仓鼠卵巢细胞和小鼠外周血红细胞中开展了遗传毒理学研究。
大鼠3个月研究:将每组10只雄性和10只雌性大鼠通过全身吸入暴露于浓度为0、75、150、300、600或1000 ppm的α-甲基苯乙烯中,每天6小时,每周5天,共14周。另外每组10只雄性和10只雌性大鼠的临床病理学组以相同浓度暴露23天。所有大鼠均存活至研究结束,所有暴露组的平均体重与舱内对照组相似。1000 ppm雄性大鼠和600及1000 ppm雌性大鼠的肾脏重量显著增加。150 ppm及以上雄性大鼠和600及1000 ppm雌性大鼠的肝脏重量出现统计学显著增加。暴露组与舱内对照组肾透明滴积累的发生率相似,但600和1000 ppm雄性大鼠肾透明滴积累的严重程度高于舱内对照组。与肾透明滴积累一致,在暴露于α-甲基苯乙烯的雄性大鼠肾脏中检测到与暴露相关的α2μ球蛋白增加。肝脏未检测到形态学变化。
小鼠3个月研究:将每组10只雄性和10只雌性小鼠通过全身吸入暴露于浓度为0、75、150、300、600或1000 ppm的α-甲基苯乙烯中,每天6小时,每周5天,共14周。1000 ppm组的两只雌性小鼠在第3天暴露前死亡。600和1000 ppm雄性小鼠以及75、300和1000 ppm雌性小鼠的最终平均体重显著低于舱内对照组;暴露于300 ppm及以上的小鼠的最终平均体重增加量也显著更低。在1000 ppm小鼠中观察到中度至重度镇静(仅雄性)和共济失调。600和1000 ppm雌性小鼠的绝对肝脏重量以及300、600和1000 ppm雄性和雌性小鼠的相对肝脏重量显著增加。600和1000 ppm雌性小鼠的发情周期长度显著长于舱内对照组。暴露于600或1000 ppmα-甲基苯乙烯的雄性和雌性小鼠肝脏中存在最小至轻度的小叶中央性肥大。所有暴露组的雄性和雌性小鼠中,与暴露相关的鼻部病变发生率显著增加,包括鲍曼腺萎缩和增生以及嗅上皮萎缩和化生。暴露于150 ppm及以上的雌性小鼠中,以嗜酸性小球在呼吸上皮细胞质中积累为特征的透明变性发生率显著增加。
大鼠2年研究:将每组50只雄性和50只雌性大鼠通过全身吸入暴露于浓度为0、100、300或1000 ppm的α-甲基苯乙烯中,每天6小时,每周5天(节假日除外),共105周。暴露的雄性和雌性大鼠的存活率与舱内对照组相似。在研究的第2年,1000 ppm雄性和雌性大鼠的平均体重低于舱内对照组。两只1000 ppm雄性大鼠和一只300 ppm雄性大鼠患有肾小管癌,一只300 ppm雄性大鼠患有肾小管腺瘤。由于在2年研究结束时在300和1000 ppm雄性大鼠中观察到肿瘤,且在3个月时发现肾脏中有α2μ球蛋白积累,而这通常与肾肿瘤相关,因此制备了额外的肾脏连续切片;发现了更多有局灶性增生或腺瘤的雄性大鼠。当单张切片和连续切片合并时,1000 ppm雄性大鼠中肾小管腺瘤和癌(合并)的发生率显著高于舱内对照组。1000 ppm雄性大鼠肾乳头矿化的发生率显著增加。与舱内对照组相比,1000 ppm雄性大鼠中单核细胞白血病的发生率显著增加。在鼻部,所有暴露组的雄性和雌性小鼠基底细胞增生的发生率显著增加,1000 ppm雄性和雌性小鼠以及300 ppm雌性小鼠中嗅上皮变性的发生率增加。
小鼠2年研究:将每组50只雄性和50只雌性小鼠通过全身吸入暴露于浓度为0、100、300或600 ppm的α-甲基苯乙烯中,每天6小时,每周5天(节假日除外),共105周。所有暴露的雄性和雌性小鼠的存活率与舱内对照组相似。在整个研究过程中,600 ppm雄性小鼠的平均体重低于舱内对照组,13周后600 ppm雌性小鼠的平均体重低于舱内对照组。在研究的大部分时间里,300 ppm雄性和雌性小鼠的平均体重低于舱内对照组,但这些组在研究结束时恢复。100和600 ppm雄性小鼠以及所有暴露组的雌性小鼠中肝细胞腺瘤或癌(合并)的发生率显著增加。所有暴露组的雌性小鼠中肝细胞腺瘤的发生率显著增加,所有暴露组的雄性和雌性小鼠中肝细胞腺瘤的发生率超过舱内对照组的历史范围。600 ppm雌性小鼠中肝细胞癌和肝脏嗜酸性灶的发生率显著增加。所有暴露组的雄性和雌性小鼠中嗅上皮化生和嗅上皮上方腺体增生的发生率显著增加。此外,300和600 ppm雄性小鼠中嗅上皮萎缩显著增加。与舱内对照组相比,600 ppm雌性小鼠中肾病的发生率和严重程度增加。雄性小鼠前胃也出现上皮增生。
α-甲基苯乙烯在有或无大鼠或仓鼠肝脏代谢活化酶(S9)的情况下,对四株鼠伤寒沙门氏菌均无致突变性。α-甲基苯乙烯在有或无S9活化的情况下,均未在培养的中国仓鼠卵巢细胞中诱导染色体畸变,但在有S9存在的情况下暴露的培养物中,显著增加了姐妹染色单体交换频率。在体内,在3个月研究结束时采集的雄性小鼠血液样本中,微核红细胞频率未见显著增加。然而,在3个月研究的雌性小鼠中,1000 ppm组中观察到微核红细胞显著增加。
在这项为期2年的吸入研究条件下,基于肾小管腺瘤和癌(合并)发生率增加,有一些证据表明α-甲基苯乙烯对雄性F344/N大鼠具有致癌活性。1000 ppm雄性F344/N大鼠中单核细胞白血病发生率增加可能与α-甲基苯乙烯暴露有关。没有证据表明暴露于100、300或1000 ppm的α-甲基苯乙烯对雌性F344/N大鼠具有致癌活性。基于肝细胞腺瘤或癌(合并)发生率略有增加,有不确定证据表明α-甲基苯乙烯对雄性B6C3F1小鼠具有致癌活性。基于肝细胞腺瘤和癌发生率增加,有明确证据表明α-甲基苯乙烯对雌性B6C3F1小鼠具有致癌活性。大鼠暴露于α-甲基苯乙烯会导致肾脏毒性,在雄性中表现出一些α2μ球蛋白肾病的特征。暴露于α-甲基苯乙烯会导致雄性和雌性大鼠及小鼠的鼻部非肿瘤性病变,以及雌性小鼠的肝脏和肾脏非肿瘤性病变。